Genomics England has announced the appointment of Jonathan Symonds CBE as its new Chair to replace Sir John Chisholm, who leaves the organisation on 29 January 2019. Jonathan has been working with Genomics England since 2014 as senior non-executive director of the Genomics England Board, and as more than 30 years’ experience working within the life science sector.

Sir John Chisholm has been with Genomics England since its creation in 2013, announcing his departure shortly after December’s news that the organisation successfully sequenced 100,000 whole genomes.

Genomics England’s CEO, Professor John Mattick, is also stepping down to be temporarily replaced by Genomic England’s current Chief Scientist, Professor Mark Caulfield. Professor Caulfield will act as interim CEO, with the search for a permanent appointment beginning next week.

Sir John Chisholm said: “I am so proud and pleased with the extraordinary achievement of realising our ambition of sequencing 100,000 whole genomes within the NHS. And this felt like the right time for me to move on.

“It was an unprecedented team effort involving thousands of researchers, clinicians and others across the NHS, academia, industry, and beyond. Most especially thanks to the generosity of more than 93,000 NHS patients and their family members who continue to put their faith in Genomics England as the work to push back the boundaries of genomic science and healthcare goes on.”